Evotec SE (EVO) Payables (2009 - 2026)
Evotec SE (EVO) posted Payables of $64273.9 for Q1 2026, down 14.74% sequentially from $75387.0 in Q4 2025, and little changed YoY from $64479.5 in Q1 2025.
Evotec SE (EVO) Payables (2009 - 2026) Analysis & Trends
Evotec SE has reported Payables for 9 years, with the latest figure at $64273.9 in Q1 2026.
- Quarterly Payables changed 0.32% year-over-year to $64273.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64273.9 (changed 0.32% YoY) and the FY2025 annual result came in at $75387.0, down 99.92% from the prior year.
- Payables slipped to $64273.9 in Q1 2026 per EVO's latest filing, from $75387.0 in the prior quarter.
- Over five years, Payables peaked at $144.5 million in Q4 2023 and troughed at -$86317.4 in Q2 2022.
- A 5-year average of $28.0 million and a median of $76073.0 in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2025: Payables jumped 45.62% in 2023, then plunged 99.92% in 2025.
- Over 5 years, Payables stood at $99.2 million in 2022, then surged by 45.62% to $144.5 million in 2023, then plunged by 36.56% to $91.7 million in 2024, then slumped by 99.92% to $75387.0 in 2025, then fell by 14.74% to $64273.9 in 2026.
- According to Business Quant data, Payables over the past three periods registered $64273.9, $75387.0, and $57850.7 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 986.00 Mn |
| 10 | Evotec SE | 692.56 Mn | 692.08 Mn | - | 64,273.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,273.94 |
| Dec 31, 2025 | 75,386.95 |
| Sep 30, 2025 | 57,850.69 |
| Jun 30, 2025 | 65,635.55 |
| Mar 31, 2025 | 64,479.46 |
| Dec 31, 2024 | 91.68 Mn |
| Sep 30, 2024 | 76,758.95 |
| Dec 31, 2023 | 144.52 Mn |
| Dec 31, 2022 | 99.25 Mn |
| Sep 30, 2022 | 84,659.75 |
| Jun 30, 2022 | -86,317.42 |
| Mar 31, 2022 | 83,882.40 |
| Dec 31, 2021 | 83.05 Mn |
| Sep 30, 2021 | 66,889.18 |
| Dec 31, 2020 | 50.73 Mn |
| Sep 30, 2010 | 7,946.49 |
| Jun 30, 2010 | 8,444.52 |
| Mar 31, 2010 | 1,166.74 |
| Dec 31, 2009 | 7,730.70 |
| Jun 30, 2009 | 10.91 Mn |